As of today, October 31, 2018 at 9:06pm EST, Presbia PLC (NASDAQ:LENS) has 17.16M shares outstanding with a float of 9.49M.

Presbia PLC’s yearly revenue of $16K provides them a gross profit of -$83K. Their current share price is $0.72. LENS is in the Healthcare sector and Medical Instruments & Supplies industry.



Presbia is a medical device company focused on the development of the presbyopia-correcting Presbia Flexivue Microlens™ – an innovative solution for the common age-related loss of the ability to read or focus on near objects. The 3mm diameter lens is implanted in a corneal pocket created by a femtosecond laser. Learn more about the Microlens solution.

This solution responds to the market’s need for a surgical procedure that is safe, effective, quick and easy to learn and implement. The Presbia Flexivue Microlens™ solution relies on surgical equipment already in use at most eye surgery centers. Most distinguishing, the Presbia Flexivue Microlens™ is designed to be removable, meaning that the lens can be removed and replaced without any residual effect on the eye.

The Presbia Flexivue Microlens™ has received the CE mark for the European Economic Area, allowing the lens to be commercially available across Europe. The Presbia Flexivue Microlens™ has not been approved by the FDA and is not commercially available in the United States. Presbia is an ISO 13485 approved company.

Check out SOME latest tagged press releases: